Literature DB >> 3804034

Long-term effects on bladder function following radical hysterectomy with and without postoperative radiation.

L C Bandy, D L Clarke-Pearson, J T Soper, D G Mutch, J MacMillan, W T Creasman.   

Abstract

Sixty-one patients with Stage IB cervical carcinoma treated initially by Type III radical hysterectomy underwent water cystometry 6 or more months after surgery. Adjunctive pelvic radiation in 10 patients was associated with significantly more contracted (P less than 0.001) and unstable (P less than 0.01) bladders than surgery alone. The necessity for bladder drainage 30 or more days after surgery alone in 17 patients was associated with significantly worse (P less than 0.05) long-term post-void residual and total bladder capacity as well as volume for first urge to void compared to 34 patients treated only with surgery who required short-term drainage. Management of bladder drainage following radical hysterectomy is discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3804034     DOI: 10.1016/0090-8258(87)90269-1

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Long-term lower urinary tract dysfunction after radical hysterectomy in patients with early postoperative voiding dysfunction.

Authors:  Tarinee Manchana; Chalisa Prasartsakulchai; Apirak Santingamkun
Journal:  Int Urogynecol J       Date:  2009-09-04       Impact factor: 2.894

2.  The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer.

Authors:  Georgia A McCann; Susanne K Taege; Christina E Boutsicaris; Gary S Phillips; Eric L Eisenhauer; Jeffrey M Fowler; David M O'Malley; Larry J Copeland; David E Cohn; Ritu Salani
Journal:  Gynecol Oncol       Date:  2012-11-05       Impact factor: 5.482

3.  Androgen deprivation modulates the inflammatory response induced by irradiation.

Authors:  Chun-Te Wu; Wen-Cheng Chen; Paul-Yang Lin; Shuen-Kuei Liao; Miao-Fen Chen
Journal:  BMC Cancer       Date:  2009-03-25       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.